{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T01:50:03Z","timestamp":1783129803026,"version":"3.54.6"},"reference-count":44,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,3,14]],"date-time":"2023-03-14T00:00:00Z","timestamp":1678752000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:sec><jats:title>Introduction<\/jats:title><jats:p>An orally administered amino acid-based test supplement was recently shown to increase human growth hormone (hGH) in healthy adults. This prospective, observational, single-center, single-arm cohort study investigated the effects of 24 weeks of daily oral administration of the test supplement in individuals with stress-related weight gain, fibromyalgia (FM) and stress-related low-normal hGH production (15-30<jats:sup>th<\/jats:sup> percentile for age-appropriate levels) on insulin-like growth factor 1 (IGF-1), an indicator of hGH levels caused by stress related stimulation of somatostatin.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Participants continued to receive standard care. The primary endpoint was the change from baseline to endpoint (Week 24) in serum IGF-1. Additional endpoints included the change in body weight, clinical symptoms (assessed with the Revised Fibromyalgia Impact Questionnaire [FIQR], range 0-100, and Perceived Stress Scale [PSS], range 0-40), fasting cardiometabolic markers, tolerability, and safety. The study enrolled 84 fibromyalgia patients with low-normal age-adjusted IGF-1 serum levels. High mean \u00b1 Standard Deviation (SD) baseline FIQR and PSS scores of 76 \u00b1 16 and 32 \u00b1 5, respectively, indicated poor to moderate symptom management with standard care. All individuals completed 24 weeks.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Serum IGF-1 levels increased with a Week 24 mean\u00b1 Standard Error (SE) change of 28.4 \u00b1 3.0 ng\/mL (<jats:italic>p<\/jats:italic>&amp;lt;0.001). Body weight was reduced with a Week 24 mean \u00b1 SE change of -5.5 \u00b1 0.3\u00a0kg (<jats:italic>p<\/jats:italic>&amp;lt;0.001) (a 6.5% weight loss from baseline). The change from baseline in FIQR and PSS scores were -29.1 \u00b1 1.1 and -20.0 \u00b1 0.8, respectively (both <jats:italic>p<\/jats:italic>&amp;lt;0.001), indicating a substantial improvement. Statistically significant improvements from baseline to Week 24 were observed in systolic and diastolic blood pressure, HbA1c, LDL and HDL cholesterol, and triglycerides (all <jats:italic>p<\/jats:italic>&amp;lt;0.001). The supplement was well tolerated; no adverse events were reported.<\/jats:p><\/jats:sec><jats:sec><jats:title>Discussion<\/jats:title><jats:p>Sustained augmentation of IGF-1 with the test supplement may represent a novel method of improving clinical symptoms, including stress-related weight gain, in individuals with fibromyalgia and stress-associated low-normal hGH.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fendo.2023.1053692","type":"journal-article","created":{"date-parts":[[2023,3,14]],"date-time":"2023-03-14T06:12:32Z","timestamp":1678774352000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":4,"title":["Stress-associated weight gain, fibromyalgia symptoms, cardiometabolic markers, and human growth hormone suppression respond to an amino acid supplement blend: Results of a prospective, cohort study"],"prefix":"10.3389","volume":"14","author":[{"given":"Susan","family":"Pekarovics","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam","family":"Beres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colleen","family":"Kelly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonja K.","family":"Billes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy L.","family":"Heaton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,3,14]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/j.mayocp.2015.03.014","article-title":"Fibromyalgia and related conditions","volume":"90","author":"Clauw","year":"2015","journal-title":"Mayo Clin Proc"},{"key":"B2","doi-asserted-by":"publisher","first-page":"k1309","DOI":"10.1136\/bmj.k1309","article-title":"Movement on pain","volume":"360","author":"Moberly","year":"2018","journal-title":"BMJ"},{"key":"B3","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1001\/jama.2013.284971","article-title":"JAMA patient page. fibromyalgia","volume":"311","author":"Sugerman","year":"2014","journal-title":"JAMA"},{"key":"B4","unstructured":"About fibromyalgia2018"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1002\/ejp.1252","article-title":"Comorbid fibromyalgia: A qualitative review of prevalence and importance","volume":"22","author":"Fitzcharles","year":"2018","journal-title":"Eur J Pain"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1002\/acr.20140","article-title":"The American college of rheumatology preliminary diagnostic criteria for fibromyalgia and measurement of symptom severity","volume":"62","author":"Wolfe","year":"2010","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyg.2022.949256","article-title":"On the superiority of a combination of aerobic and resistance exercise for fibromyalgia syndrome: A network meta-analysis","volume":"13","author":"Chen","year":"2022","journal-title":"Front Psychol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/09593985.2022.2119906","article-title":"Effects of aquatic physical therapy on clinical symptoms, physical function, and quality of life in patients with fibromyalgia: A systematic review and meta-analysis","author":"Ma","year":"2022","journal-title":"Physiother Theory Pract"},{"key":"B9","doi-asserted-by":"publisher","first-page":"10391","DOI":"10.1038\/s41598-022-14213-x","article-title":"Effect of different types of exercise in adult subjects with fibromyalgia: a systematic review and meta-analysis of randomized clinical trials","volume":"12","author":"Couto","year":"2022","journal-title":"Sci Rep"},{"key":"B10","doi-asserted-by":"publisher","first-page":"e8688","DOI":"10.1590\/1414-431X20198688","article-title":"Does whole body vibration exercise improve oxidative stress markers in women with fibromyalgia","volume":"52","author":"Santos","year":"2019","journal-title":"Braz J Med Biol Res"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1007\/s11926-002-0039-4","article-title":"Adult growth hormone deficiency in patients with fibromyalgia","volume":"4","author":"Bennett","year":"2002","journal-title":"Curr Rheumatol Rep"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1002\/art.10209","article-title":"Impaired growth hormone secretion in fibromyalgia patients: evidence for augmented hypothalamic somatostatin tone","volume":"46","author":"Paiva","year":"2002","journal-title":"Arthritis Rheum"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1210\/jc.84.9.3378","article-title":"The growth hormone (GH)-releasing hormone-GH-insulin-like growth factor-1 axis in patients with fibromyalgia syndrome","volume":"84","author":"Leal-Cerro","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1210\/jc.86.4.1672","article-title":"Decreased nocturnal levels of prolactin and growth hormone in women with fibromyalgia","volume":"86","author":"Landis","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9343(97)00351-3","article-title":"A randomized, double-blind, placebo-controlled study of growth hormone in the treatment of fibromyalgia","volume":"104","author":"Bennett","year":"1998","journal-title":"Am J Med"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1016\/j.pain.2012.02.012","article-title":"Growth hormone treatment for sustained pain reduction and improvement in quality of life in severe fibromyalgia","volume":"153","author":"Cuatrecasas","year":"2012","journal-title":"Pain"},{"key":"B17","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1038\/nrendo.2018.22","article-title":"Growth hormone - past, present and future","volume":"14","author":"Ranke","year":"2018","journal-title":"Nat Rev Endocrinol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1097\/MJT.0000000000000893","article-title":"Increased human growth hormone after oral consumption of an amino acid supplement: Results of a randomized, placebo-controlled, double-blind, crossover study in healthy subjects","volume":"27","author":"Tam","year":"2020","journal-title":"Am J Ther"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1089\/jmf.2020.0109","article-title":"Mechanism for the increase in human growth hormone with administration of a novel test supplement and results indicating improved physical fitness and sleep efficiency","volume":"24","author":"Heaton","year":"2020","journal-title":"J Med Food"},{"key":"B20","doi-asserted-by":"publisher","first-page":"R120","DOI":"10.1186\/ar2783","article-title":"The revised fibromyalgia impact questionnaire (FIQR): Validation and psychometric properties","volume":"11","author":"Bennett","year":"2009","journal-title":"Arthritis Res Ther"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.2307\/2136404","article-title":"A global measure of perceived stress","volume":"24","author":"Cohen","year":"1983","journal-title":"J Health Soc Behav"},{"key":"B22","doi-asserted-by":"crossref","DOI":"10.1016\/B978-0-323-29738-7.00008-3","article-title":"Pituitary physiology and diagnostic evaluation","volume-title":"Williams book of endocrinology","author":"Kaiser","year":"2016"},{"key":"B23","doi-asserted-by":"crossref","DOI":"10.1016\/B978-0-323-29738-7.00007-1","article-title":"Neuroendocrinology","volume-title":"Williams book of endocrinology","author":"Low","year":"2016"},{"key":"B24","doi-asserted-by":"crossref","DOI":"10.1016\/B978-0-323-29738-7.00027-7","article-title":"Endocrinology and aging","volume-title":"Williams textbook of endocrinology","author":"Lamberts","year":"2016"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-64-1-51","article-title":"Effects of sex and age on the 24-hour profile of growth hormone secretion in man: importance of endogenous estradiol concentrations","volume":"64","author":"Ho","year":"1987","journal-title":"J Clin Endocrinol Metab"},{"key":"B26","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1186\/1471-2474-8-119","article-title":"Growth hormone as concomitant treatment in severe fibromyalgia associated with low IGF-1 serum levels","volume":"8","author":"Cuatrecasas","year":"2007","journal-title":"A pilot study BMC Musculoskelet Disord"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1007\/s003930050240","article-title":"Disordered growth hormone secretion in fibromyalgia: a review of recent findings and a hypothesized etiology","volume":"57","author":"Bennett","year":"1998","journal-title":"Z Rheumatol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1007\/s13760-018-01063-6","article-title":"Relationship of leptin, growth hormone, and insulin-like growth factor levels with body mass index and disease severity in patients with fibromyalgia syndrome","volume":"120","author":"Koca","year":"2020","journal-title":"Acta Neurol Belg"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-010-1618-8","article-title":"The prevalence of fibromyalgia syndrome in a group of patients with diabetes mellitus","volume":"32","author":"Yanmaz","year":"2012","journal-title":"Rheumatol Int"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.2337\/dc11-1833","article-title":"The association between IGF-I and insulin resistance: a general population study in Danish adults","volume":"35","author":"Friedrich","year":"2012","journal-title":"Diabetes Care"},{"key":"B31","doi-asserted-by":"publisher","first-page":"vii","DOI":"10.1016\/j.ecl.2012.04.017","article-title":"Metabolic actions of insulin-like growth factor-I in normal physiology and diabetes","volume":"41","author":"Clemmons","year":"2012","journal-title":"Endocrinol Metab Clin North Am"},{"key":"B32","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s12967-015-0762-z","article-title":"Insulin-like growth factor-1 deficiency and metabolic syndrome","volume":"14","author":"Aguirre","year":"2016","journal-title":"J Transl Med"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1111\/dom.12971","article-title":"Effect of weight reduction on glycated haemoglobin in weight loss trials in patients with type 2 diabetes","volume":"19","author":"Gummesson","year":"2017","journal-title":"Diabetes Obes Metab"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1111\/obr.12433","article-title":"Interventions that cause weight loss and the impact on cardiovascular risk factors: a systematic review and meta-analysis","volume":"17","author":"Zomer","year":"2016","journal-title":"Obes Rev"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-2982.2005.01048.x","article-title":"Glial cell line-derived neurotrophic factor and somatostatin levels in cerebrospinal fluid of patients affected by chronic migraine and fibromyalgia","volume":"26","author":"Sarchielli","year":"2006","journal-title":"Cephalalgia"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1016\/j.peptides.2012.12.022","article-title":"Modulation of the adaptive response to stress by brain activation of selective somatostatin receptor subtypes","volume":"42","author":"Stengel","year":"2013","journal-title":"Peptides"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.3390\/biology11060935","article-title":"Oxidative stress biomarkers and quality of life are contributing factors of muscle pain and lean body mass in patients with fibromyalgia","volume":"11","author":"Dos Santos","year":"2022","journal-title":"Biol (Basel)"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph18126237","article-title":"Impact of reducing sitting time in women with fibromyalgia and obesity: A randomized controlled trial","volume":"18","author":"Rodr\u00edguez-Roca","year":"2021","journal-title":"Int J Environ Res Public Health"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2021.672370","article-title":"Theory: Treatments for prolonged ICU patients may provide new therapeutic avenues for myalgic encephalomyelitis\/chronic fatigue syndrome","volume":"8","author":"Stanculescu","year":"2021","journal-title":"Front Med"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1111\/jgs.13135","article-title":"Higher perceived stress scale scores are associated with higher pain intensity and pain interference levels in older adults","volume":"62","author":"White","year":"2014","journal-title":"J Am Geriatr Soc"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.2147\/JPR.S37056","article-title":"Psychological control is a key modulator of fibromyalgia symptoms and comorbidities","volume":"5","author":"Malin","year":"2012","journal-title":"J Pain Res"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-67-6-1186","article-title":"Arginine stimulates growth hormone secretion by suppressing endogenous somatostatin secretion","volume":"67","author":"Alba-Roth","year":"1988","journal-title":"J Clin Endocrinol Metab"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1159\/000125890","article-title":"Arginine reinstates the somatotrope responsiveness to intermittent growth hormone-releasing hormone administration in normal adults","volume":"54","author":"Ghigo","year":"1991","journal-title":"Neuroendocrinology"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM196906262802603","article-title":"Arginine-initiated release of human growth hormone. factors modifying the response in normal man","volume":"280","author":"Merimee","year":"1969","journal-title":"N Engl J Med"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2023.1053692\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,14]],"date-time":"2023-03-14T06:12:38Z","timestamp":1678774358000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2023.1053692\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,14]]},"references-count":44,"alternative-id":["10.3389\/fendo.2023.1053692"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2023.1053692","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,14]]},"article-number":"1053692"}}